Programme
-
Monday 27 July
14.00 - 15.00W1: Rhythm and Blues: advances in understanding and treatment of Bipolar DisordersChair: Professor Allan Young, Institute of Psychiatry, Psychology and Neuroscience, King'’'s College London
Whats emotionally unstable about early onset bipolar?
Dr Aditya Sharma, Clinical Senior Lecturer and Hon Consultant in Child and Adolescent Psychiatry, Newcastle University
Neurobiology and treatments for mania
Dr Sameer Jauhar, Institute of Psychiatry, Psychology & Neuroscience, King's College London
Dissecting bipolar disorder using clinical and mobile assessments
Professor Kathleen Ries Merikangas, Ph.D., Senior Investigator & Chief, Genetic & Epidemiology Research Unit -
Monday 27 July
15.30 - 16.30W2: Implications of the ICD-11 Classification of Personality DisordersChair: Professor Mike Crawford, Professor in Mental Health Research, Centre for Psychiatry, Imperial College, London
ICD-11 Personality Disorders: A new way of conceptualising personality pathology
Professor Peter Tyrer and Roger Mulder, Division of Clinical Psychiatry, Imperial College and Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Implications of ICD-11 personality disorders in clinical practice: an eight-year clinical trial
Dr Rahil Sanatinia, Research Associate, Centre for Psychiatry, Imperial College London -
Tuesday 28 July
14.00 - 15.00W3: Talking about mental health in the media: platforms, pitfalls, and new directionsChair: Dr Niall Boyce, Editor, The Lancet Psychiatry
Scientific journals and social media: an unhappy marriage?
Derek Tracy, The British Journal of Psychiatry
Facilitating democratic conversations about mental health research welcome to the woodland!
André Tomlin, The Mental Elf
“Why on earth would you want to do that?”: One psychiatrist’s experience of writing for the mainstream media
Dr Mariam Alexander, West London NHS Trust
What editors want, what readers want, and why it matters
David Shariatmadari, Opinion Editor, The Guardian -
Tuesday 28 July
15.30 - 16.30W4: Frequent Attendance at Emergency Departments with Mental Health Needs – What Helps, What’s it Like and Who Can Help?”Chair: Dr Catherine Hayhurst, Consultant in Emergency Medicine, Cambridge University Hospitals NHS Foundation Trust and Chair of Mental Health Subcommittee, Royal College of Emergency Medicine
What’s the Evidence? An Overview of Research on Frequent Attendance
Dr Alex Thomson, Consultant Liaison Psychiatrist, Central and North West London NHS Foundation Trust and Committee Member, RCPsych Liaison, Psychiatry Faculty Executive Committee
What’s it Like? The Experience of Attending Emergency Departments Frequently with Mental Health Needs
Dr Emma McAllister, Lived Experience Advisor, UK and Patient Representative, RCPsych Liaison Psychiatry Faculty Executive Committee
What Helps? Top Tips for Achieving a Service with Impact
Ms Rhian Monteith, Advanced Paramedic and Specialist Advisor, NHS RightCare -
Monday 10 August
10.30 - 11.30W5: Monoamine oxidase inhibitors (MAOIs) in patients with treatment-resistant depression or anxiety disorders: time for a reconsideration?
Speakers
Professor David Baldwin, and Dr Samuel Chamberlain, University Department of Psychiatry, Faculty of Medicine, University of Southampton, United Kingdom
We will describe the biological action of MAOIs and consider the evidence-base for their use in particular indications, incorporating available meta-analyses and clinical trial data. We will also consider safety issues including early and late adverse events; drug-drug interactions (including those likely to be overlooked such as informing patients about cold medications that can interact, and potential interactions with anesthetic agents); and dietary/food restrictions. This practical advice will include pointers to useful resources, including a dietary restrictions leaflet that can be discussed and shared with patients, and guidelines for treatment of depression and anxiety. -
Monday 10 August
14.00 - 15.00W6: MDMA, psilocybin, and cannabis - the future sound of psychiatryMedical cannabis: The future is green
Dr Chloe Sakal, Drug Science
MDMA therapy for treating alcoholism
Dr Ben Sessa, Imperial College London
Psilocybin therapy for treating depression
Dr Tim Williams, Clinical Director AWP -
Tuesday 11 August
14.00 - 15.00W7: Recent advances in dementiaChair: Prof John O’Brien, Department of Psychiatry, University of Cambridge
Watch your step: Potential clinical applications of gait analysis in dementia
Dr Ríona Mc Ardle, Newcastle University
New insights from Epigenetics: DNA methylation alterations in Lewy Body Dementia
Dr Leo Chouliaras, Department of Psychiatry, University of Cambridge
Improving the diagnosis and management of Lewy body dementia: The DIAMOND-Lewy study
Prof John O’Brien, Department of Psychiatry, University of Cambridge -
Tuesday 11 August
15.30 - 16.30W8: Can we PREVENT dementia?Chair: Prof John O’Brien, Department of Psychiatry, University of Cambridge
Can we prevent dementia?
Prof Craig Ritchie, Centre for Clinical Brain Sciences, University of Edinburgh
Can imaging detect changes 20 years before dementia onset?
Prof John O’Brien, Department of Psychiatry, University of Cambridge
Virtual reality as a putative tool for the early diagnosis of dementia
Ms Coco Newton, Department of Psychiatry, University of Cambridge -
Monday 24 August
10.00 - 12.30W9: Treatment Resistant PsychosisPart 1
Chair: Dr Fiona Gaughran, Lead Consultant, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Reader, Institute of Psychiatry, Psychology and Neuroscience
Cannabis and violence: is any association mediated by Paranoia?
Sir Robin Murray, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience
Treatment resistant psychosis in children and adolescents
Dr Johnny Downs Institute of Psychiatry, Psychology and Neuroscience and Dr Marinos Kyriakopoulos, CAMHS, South London and Maudsley NHS Foundation Trust
Part 2
Chair: Dr Fiona Gaughran, Lead Consultant, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Reader, Institute of Psychiatry, Psychology and NeuroscienceGenomics and Psychosis –when will the lab move into the clinic?Dr Mandy Johnstone National Psychosis Unit, South London and Maudsley NHS FoundationProfessor James MacCabe, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience
Clozapine Treatment and risk of COVID-19
A fine balance; quality and safe use of clozapine
A/Prof Dan Siskind, Clinical Academic Psychiatrist, Metro South Addiction and Mental Health Service, Brisbane, Australia -
Tuesday 25 August
10.30-11.30W10: Genetic disorders: applying science in clinical practiceChair: Dr Ken Courtenay, Chair of the Faculty of Intellectual Disability, Royal College of Psychiatrists.
Alzheimer’s Disease in Down Syndrome: a Genetic Condition with Variable Onset
Prof. Andre Strydom, Professor of Intellectual Disabilities
Genetic Testing in Clinical Practice: Towards a Cross-disciplinary Framework
Dr Jana De Villiers, Consultant Psychiatrist in Intellectual Disability, Forensic Network Clinical Lead for Intellectual Disabilities
Single Gene Disorders: Relevance to Patients, Families, and Clinicians
Dr Lindsay Mizen, Consultant Psychiatrist West Lothian Community Learning Disability Team, Senior Clinical Research Fellow University of Edinburgh -
Tuesday 25 August
14.00 - 15.00W11: Improving services for people with substance use and comorbid mental disorders
Fighting The Friendly Foe. Personal Experience of Alcohol Addiction
Diane Goslar, Expert by Experience
Our Invisible Addicts” The changing face of alcohol and drug addiction
Dr Tony Rao, Consultant Old Age Psychiatrists, South London and Maudsley NHS Foundation Trust
Frightened, alone and away from home” Personal experience of drug addiction and co-morbid mental disorder
Rachel Bannister, Expert by Experience
Additional Resources
Rachel Bannister on struggling with addiction: “You just need a hand to hold to see you through” -
Tuesday 25 August
15.30 - 16.30W12: Management of sleep disorders: A review of the updated British Association for Psychopharmacology GuidelinesChair: Professor Hamish McAllister-Williams, Newcastle University
Assessment of sleep problems
Dr Kirstie Anderson, Newcastle upon Tyne Hospitals NHS Foundation Trust
Treatment of insomnia
Dr Sue Wilson, Imperial College London
Treatment of other sleep problems
Dr Hugh Selsick, The Royal London Hospital for Integrated Medicine -
Monday 7 September
15.30 - 16.30W13: Advances in treatment of complex mood disordersChair: Professor Allan Young, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Next Generation Rapid Acting Antidepressants
Carlos A. Zarate, Jr., M.D, National Institute of Mental Health
An Update on Pharmacological Augmentation Strategies for Major Depressive Disorder
Professor Anthony Cleare, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Is transcranial direct current stimulation (tDCS) a treatment for depression?
Professor Cynthia Fu, University of East London, Centre for Affective Disorders, IoPPN, -
Tuesday 8 September
14.00 - 15.00W14: Understanding and managing clinical risk for women with severe mental illness during pregnancy and postpartumChair: Dr Liz McDonald, Clinical Lead for PMH Bursary Programme, RCPsych, Visiting Lecturer, Tavistock and Portman Trust, Hon. Consultant, ELFT
Bipolar disorder and Postpartum Psychosis – can we individualise risk?
Professor Ian Jones, Cardiff University
Schizophrenia in women: what risk issues need to be considered in the perinatal period?
Dr Liz McDonald, Clinical Lead for PMH Bursary Programme, RCPsych, Visiting Lecturer, Tavistock and Portman Trust, Hon. Consultant, ELFT
Reducing risk of maternal suicide: lessons from the Confidential Enquiries into Maternal Deaths
Dr Roch Cantwell, Consultant Perinatal Psychiatrist, Lead Clinician, Perinatal Mental Health Network Scotland -
Tuesday 8 September
15.30 - 16.30W15: Ketamine: new trial data and use in practiceChair: Prof Rupert McShane, Oxford Health NHS Foundation Trust and Dept Psychiatry, University of Oxford
Ketamine to prevent Alcohol RElapse (KARE): an MRC funded study in Exeter and UCL
Professor Celia Morgan, Professor of Psychopharmacology, Exeter University
Open label extension data from an RCT of daily oral esketamine from NetherlandsJolien Veraart, Department of Psychiatry, University of Groningen, Netherlands
Use of ketamine and related antidepressants in UK
Prof Rupert McShane, Oxford Health NHS Foundation Trust and Dep Psychiatry, University of Oxford -
Tuesday 22 September
10.00 - 16.30W16: Core skills in neuropsychiatry
This is a full day training course on Disorders at the Interface of Neurology and Psychiatry.
10.00 - 11.00
Neurological examination in 5 minutes
Adam Zeman
Cognitive examination beyond the mini mental state examination
Adam Zeman
11.30 - 12.30
Chronic Traumatic Encephalopathy- the story so far
William Stewart
A clinical approach to traumatic brain injury
Alan Carson
14.00 - 15.00
If if bleeds, we can kill it: challenging fate in Huntington’s disease with targeted genetic therapies
Edward Wild
The neuropsychiatry of COVID
Tim Nicholson
15.30 - 16.30
Cognitive Behavioural Therapy for dissociative seizures- the CODES study
Laura Goldstein
What is Scan Negative Cauda Equina Syndrome
Ingrid Hoeritzauer